| 000 | 01177 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516035956.0 | ||
| 264 | 0 | _c20110823 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a0392-856X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Menthon, Mathilde | |
| 245 | 0 | 0 |
_aTreating polyarteritis nodosa: current state of the art. _h[electronic resource] |
| 260 |
_bClinical and experimental rheumatology _c |
||
| 300 |
_aS110-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aPlasmapheresis |
| 650 | 0 | 4 |
_aPolyarteritis Nodosa _xclassification |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMahr, Alfred | |
| 773 | 0 |
_tClinical and experimental rheumatology _gvol. 29 _gno. 1 Suppl 64 _gp. S110-6 |
|
| 999 |
_c20848487 _d20848487 |
||